<ul><li>Bharat Biotech is prepared to start Covid-19 vaccine production as needed, including adjustments for new variants.</li><li>The company has developed Covaxin, India’s first indigenous Covid-19 vaccine, and the world’s first intranasal vaccine iNCOVACC.</li><li>They have scaled up manufacturing capacity to one billion doses annually and continue to work closely with regulatory bodies.</li><li>Inactivated vaccines like Covaxin are complex and costly to manufacture, but Bharat Biotech has systems in place to increase production.</li></ul>

Bharat Bio ready to commence Covid-19 vaccines’ production if required: Suchitra Ella

Discover more